Børsen
Investors will be particularly focused on any indications of how significant an issue counterfeit medicine has become for Novo Nordisk when the company releases its earnings report on Wednesday.
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?